Naseem Zojwalla
CIK 1905871 · CHIEF MEDICAL OFFICER · last filed 2026-02-04
Naseem Zojwalla is a CHIEF MEDICAL OFFICER who has filed 21 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for OLMA, was dated Feb 4, 2026. Across all open-market trades the lifetime net is −$8.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.53M
1
21
-$7.99M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OLMA | CHIEF MEDICAL OFFICER | 146,815 | $10.43 | $1.53M | -$7.99M | 14 | 2026-02-04 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-04 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2025-12-23 | OLMA | Notice (144) | −99,509 | -$2.75M | EDGAR |
| 2025-12-23 | OLMA | Mixed | −129,509 | -$5.87M | EDGAR |
| 2025-12-22 | OLMA | Notice (144) | −100,000 | -$2.80M | EDGAR |
| 2025-12-19 | OLMA | Notice (144) | −70,000 | -$1.97M | EDGAR |
| 2025-03-03 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2024-12-17 | OLMA | Exer (M) | +14,000 | $68.2K | EDGAR |
| 2024-12-11 | OLMA | Notice (144) | −14,522 | -$126.1K | EDGAR |
| 2024-12-11 | OLMA | Mixed | +24,195 | -$250.5K | EDGAR |
| 2024-12-10 | OLMA | Notice (144) | −13,283 | -$124.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.